Alison Strath

@alisonstrath.bsky.social

Chief Pharmaceutical Officer for Scotland @scotgovhealth Emeritus Professor @RGUpharmacy supporter of @dundeeunitedfc

New Lancet paper 'The cost of not investing in the first 1000 days'. Cites our Cochrane review on preschool-based feeding programmes in socio-economically deprived settings. FEED STARVING CHILDREN in a timely way. Later (when they're older) may be too late. www.thelancet.com/journals/lan... 🧪

The cost of not investing in the next 1000 days: implications for policy and practice

Building on the evidence from the first paper in this Series highlighting the fundamental importance of healthy and nurturing environments for children's growth and development in the next 1000 days (...

thelancet.com

My UK chief pharmaceutical officers colleagues & I have provided advice to help pharmacy professionals wanting to take part in the debate on assisted dying. This follows similar advice recently issued to doctors and nurses: www.gov.uk/government/p...

Assisted dying bill debate: advice to pharmacy professionals

The UK chief pharmaceutical officers have given advice to help pharmacists and pharmacy technicians wanting to take part in the assisted dying debate.

gov.uk

For me the best key insight of this paper was that we could take an existing large and complex model and fit it, using relatively simple means, to a new and emerging situation. It worked well and gave rapid insight into the emerging variant outbreak. #IDModelling

Chris Banks@banks.ac · 2y ago

Finally! 🎉 Our last paper on the early dynamics of the SARS-CoV-2 Omicron outbreak in Scotland is now published in Epidemics! Read it here: doi.org/10.1016/j.ep... #SARSCoV2 #Omicron #PublicHealth #IDSky #EpiSky

Modelling plausible scenarios for the Omicron SARS-CoV-2 variant from early-stage surveillance. Epidemics 2024.